Why are peptides attractive as immunotherapeutic agents?

Later this month, we're hosting the TIDES 2014 Event.  Over the next few days, we'll be going back and looking at some of the one on one interviews we conducted with our speakers.  We'll start out by looking at the conversation we had with Eric Von Hofe, President of Antigen Express.

We started out by asking Eric:

Why are peptides attractive as immunotherapeutic agents?

His answer:

The main reason they are so attractive is that they represent the minimal agent needed to
generate an immune response. So, that’s always important in that if you have a lot of extra
agents, there is a potential for getting some non-specific toxic effects. The immune systemworks really just by recognizing the minimal units. By using them you know that you can getthe specific response that you want and really minimize the potential for any sort of toxic sideeffects. The other reason is that they are fully synthetic. So, they are very easy to make, very rapid and easy to scale-up and they are off-the-shelf products.

Read Dr. Von Hofe's full interview here.

Dr. Von Hofe will present the case study Peptide-Based Vaccines in the New Era of Cancer Immunotherapy on Tuesday, May 13.  For more information on his presentation and the rest of the program, download the agenda.  As a reader of this blog, when you register to join us May 12-15 in Providence, Rhode Island, you're eligible to save 20% off the standard rate!  Simply register to join us and mention priority code XB14180BLOG.  Have any questions?  Email Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |